EN-US Sun, 19 May 2013 21:11:17 -0400 244601 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yMTo2BcC_w0/trius-therapeutics-remains-one-of-our-best-ideas-analyst-blog-cm244601 Investing Business Stocks By Jason Napodano, CFA On May 7, 2013,  Trius Therapeutics (NasdaqGM: TSRX )  reported  financial results  for the first quarter 2013. Total revenues in the<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/yMTo2BcC_w0" height="1" width="1"/> Wed, 08 May 2013 18:10:01 Z 2013-05-08T15:28:14Z Zacks Equity Research PFE TSRX http://www.nasdaq.com/article/trius-therapeutics-remains-one-of-our-best-ideas-analyst-blog-cm244601